Beauty Health Hold Rating Reiterated Amid Strategic Shifts and Market Challenges
I'm PortAI, I can summarize articles.
Susan Anderson from Canaccord Genuity reiterated a Hold rating on Beauty Health with a price target of $1.50. Despite a 10.3% decline in third-quarter sales year-over-year, the company exceeded expectations. New CEO Pedro Malha's strategic priorities aim to expand the device footprint and enhance repeat treatments. However, challenges such as the transition to a distributor model in China and a high-interest rate environment contribute to a cautious outlook. Over the past six months, SKIN's price increased by 22.86%, from $1.050 to $1.290.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments